Role of Notch signaling pathway in pancreatic cancer

被引：3

作者：

Gao, Jiankun ^{[1
]}

Long, Bo ^{[2
]}

Wang, Zhiwei ^{[3
,4
]}

机构：

[1] Sichuan Coll Trandit Chinese Med, Mianyang, Sichuan, Peoples R China

[2] Mianyang 404 Hosp, Dept Infect Dis, Mianyang, Sichuan, Peoples R China

[3] Soochow Univ, Jiangsu Inst Hematol, Affiliated Hosp 1, Cyrus Tang Hematol Ctr, Suzhou 215123, Peoples R China

[4] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Pathol, 330 Brookline Ave,CLS 628B, Boston, MA 02215 USA

来源：

AMERICAN JOURNAL OF CANCER RESEARCH | 2017年 / 7卷 / 02期

基金：

中国国家自然科学基金;

关键词：

Pancreatic cancer; notch; cellular signaling; therapy; target; NF-KAPPA-B; INHIBITS CELL-GROWTH; EPITHELIAL-MESENCHYMAL TRANSITION; SMALL-MOLECULE INHIBITOR; RECEPTOR-RELATED PROTEIN; ASPARAGINYL BETA-HYDROXYLASE; STEM-CELLS; TUMOR-SUPPRESSOR; SONIC-HEDGEHOG; IN-VITRO;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Pancreatic cancer (PC) is one of the highly aggressive malignancies in the United States. It has been shown that multiple signaling pathways are involved in the pathogenesis of PC, such as JNK, PI3K/AKT, Rho GTPase, Hedgehog (Hh) and Skp2. In recent years, accumulated evidence has demonstrated that Notch signaling pathway plays critical roles in the development and progression of PC. Therefore, in this review we discuss the recent literature regarding the function and regulation of Notch in the pathogenesis of PC. Moreover, we describe that Notch signaling pathway could be down-regulated by its inhibitors or natural compounds, which could be a novel approach for the treatment of PC patients.

引用

页码：173 / 186

页数：14

共 147 条

[1] A Cell-Surface β-Hydroxylase Is a Biomarker and Therapeutic Target for Hepatocellular Carcinoma [J].

Aihara, Arihiro ;

Huang, Chiung-Kuei ;

Olsen, Mark J. ;

Lin, Qiushi ;

Chung, Waihong ;

Tang, Qi ;

Dong, Xiaoqun ;

Wands, Jack R. .

HEPATOLOGY, 2014, 60 (04) :1302-1313

[2] Netrin-1 suppresses the MEK/ERK pathway and ITGB4 in pancreatic cancer [J].

An, Xi-Zhou ;

Zhao, Zhi-Guo ;

Luo, Yu-Xuan ;

Zhang, Ran ;

Tang, Xiao-Qiang ;

Hao, De-Long ;

Zhao, Xiang ;

Lv, Xiang ;

Liu, De-Pei .

ONCOTARGET, 2016, 7 (17) :24719-24733

[3]

[Anonymous], TUMOUR BIOL

[4]

[Anonymous], IEEE T POWER SYST

[5] Local overexpression of Su(H)-MAPK variants affects Notch target gene expression and adult phenotypes in Drosophila [J].

Auer, Jasmin S. ;

Nagel, Anja C. ;

Schulz, Adriana ;

Wahl, Vanessa ;

Preiss, Anette .

DATA IN BRIEF, 2015, 5 :852-863

[6] Notch signaling in pancreatic cancer: oncogene or tumor suppressor? [J].

Avila, Jacqueline L. ;

Kissil, Joseph L. .

TRENDS IN MOLECULAR MEDICINE, 2013, 19 (05) :320-327

[7] CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth [J].

Babic, AM ;

Kireeva, ML ;

Kolesnikova, TV ;

Lau, LF .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (11) :6355-6360

[8] RETRACTED: Notch-1 induces epithelial-mesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cells (Retracted article. See vol. 423, pg. 153, 2018) [J].

Bao, Bin ;

Wang, Zhiwei ;

Ali, Shadan ;

Kong, Dejuan ;

Li, Yiwei ;

Ahmad, Aamir ;

Banerjee, Sanjeev ;

Azmi, Asfar S. ;

Miele, Lucio ;

Sarkar, Fazlul H. .

CANCER LETTERS, 2011, 307 (01) :26-36

[9] Learning from Jekyll to control Hyde: Hedgehog signaling in development and cancer [J].

Barakat, Monique T. ;

Humke, Eric W. ;

Scott, Matthew P. .

TRENDS IN MOLECULAR MEDICINE, 2010, 16 (08) :337-348

[10] THE EPIDERMAL GROWTH-FACTOR [J].

BOONSTRA, J ;

RIJKEN, P ;

HUMBEL, B ;

CREMERS, F ;

VERKLEIJ, A ;

HENEGOUWEN, PVE .

CELL BIOLOGY INTERNATIONAL, 1995, 19 (05) :413-430

← 1 2 3 4 5 6 7 8 9 10 →